Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 370 articles:
HTML format
Text format



Single Articles


    January 2017
  1. ROCHA-BRISCHILIARI SC, Oliveira RR, Andrade L, Brischiliari A, et al
    The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil.
    PLoS One. 2017;12:e0168950.
    PubMed     Text format     Abstract available


  2. WANG K, Ren Y, He J
    Cavity Shaving plus Lumpectomy versus Lumpectomy Alone for Patients with Breast Cancer Undergoing Breast-Conserving Surgery: A Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0168705.
    PubMed     Text format     Abstract available


  3. WU W, Ma J, Shao N, Shi Y, et al
    Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells.
    PLoS One. 2017;12:e0169229.
    PubMed     Text format     Abstract available


  4. CHEN Q, Weng Z, Lu Y, Jia Y, et al
    An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
    PLoS One. 2017;12:e0168960.
    PubMed     Text format     Abstract available


  5. MAKHOUL I, Todorova VK, Siegel ER, Erickson SW, et al
    Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.
    PLoS One. 2017;12:e0168550.
    PubMed     Text format     Abstract available


  6. DIAS K, Dvorkin-Gheva A, Hallett RM, Wu Y, et al
    Claudin-Low Breast Cancer; Clinical & Pathological Characteristics.
    PLoS One. 2017;12:e0168669.
    PubMed     Text format     Abstract available


  7. LIU Y, Zhang Y, Li Q, Li J, et al
    MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis.
    PLoS One. 2017;12:e0170088.
    PubMed     Text format     Abstract available


  8. SINHA AK, Patel JR, Shen Y, Ueno NT, et al
    Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    PLoS One. 2017;12:e0170081.
    PubMed     Text format     Abstract available


  9. VITALI F, Cohen LD, Demartini A, Amato A, et al
    Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.
    PLoS One. 2017;12:e0170363.
    PubMed     Text format     Abstract available


  10. BRONSVELD HK, Jensen V, Vahl P, De Bruin ML, et al
    Diabetes and Breast Cancer Subtypes.
    PLoS One. 2017;12:e0170084.
    PubMed     Text format     Abstract available


  11. KIM YC, Soliman AS, Cui J, Ramadan M, et al
    Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing.
    PLoS One. 2017;12:e0167581.
    PubMed     Text format     Abstract available


  12. SINGH A, Sharma RK, Chagtoo M, Agarwal G, et al
    1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients.
    PLoS One. 2017;12:e0169330.
    PubMed     Text format     Abstract available


  13. HATOUM D, Yagoub D, Ahadi A, Nassif NT, et al
    Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer.
    PLoS One. 2017;12:e0169925.
    PubMed     Text format     Abstract available


  14. LI Y, Wang J, Lin F, Yang Y, et al
    A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines.
    PLoS One. 2017;12:e0169363.
    PubMed     Text format     Abstract available


  15. HUANG MW, Chen CW, Lin WC, Ke SW, et al
    SVM and SVM Ensembles in Breast Cancer Prediction.
    PLoS One. 2017;12:e0161501.
    PubMed     Text format     Abstract available


  16. THIRUKKUMARAN C, Shi ZQ, Thirukkumaran P, Luider J, et al
    PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
    PLoS One. 2017;12:e0168233.
    PubMed     Text format     Abstract available


  17. PILLAI SG, Zhu P, Siddappa CM, Adams DL, et al
    Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.
    PLoS One. 2017;12:e0170761.
    PubMed     Text format     Abstract available


  18. PETERS IT, van Zwet EW, Smit VT, Liefers GJ, et al
    Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study.
    PLoS One. 2017;12:e0168277.
    PubMed     Text format     Abstract available


  19. SIGLEY J, Jarzen J, Scarpinato K, Guthold M, et al
    Diffusion and Binding of Mismatch Repair Protein, MSH2, in Breast Cancer Cells at Different Stages of Neoplastic Transformation.
    PLoS One. 2017;12:e0170414.
    PubMed     Text format     Abstract available


  20. DENG J, Yang M, Jiang R, An N, et al
    Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
    PLoS One. 2017;12:e0170860.
    PubMed     Text format     Abstract available


  21. YIN K, Liu Y, Chu M, Wang Y, et al
    TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer.
    PLoS One. 2017;12:e0170573.
    PubMed     Text format     Abstract available


  22. DALM SU, Schrijver WA, Sieuwerts AM, Look MP, et al
    Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.
    PLoS One. 2017;12:e0170536.
    PubMed     Text format     Abstract available


  23. PIRES BR, Mencalha AL, Ferreira GM, de Souza WF, et al
    NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells.
    PLoS One. 2017;12:e0169622.
    PubMed     Text format     Abstract available


  24. ZIV E, Tice JA, Sprague B, Vachon CM, et al
    Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention.
    PLoS One. 2017;12:e0168601.
    PubMed     Text format     Abstract available


  25. LINDBERG P, Netter P, Koller M, Steinger B, et al
    Breast cancer survivors` recollection of their quality of life: Identifying determinants of recall bias in a longitudinal population-based trial.
    PLoS One. 2017;12:e0171519.
    PubMed     Text format     Abstract available


  26. STRUMYLAITE L, Kregzdyte R, Poskiene L, Bogusevicius A, et al
    Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women.
    PLoS One. 2017;12:e0171198.
    PubMed     Text format     Abstract available


  27. KIM TH, Chang JS, Park KS, Park J, et al
    Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial.
    PLoS One. 2017;12:e0171771.
    PubMed     Text format     Abstract available


  28. BALEKOUZOU A, Yin P, Afewerky HK, Bekolo C, et al
    Behavioral risk factors of breast cancer in Bangui of Central African Republic: A retrospective case-control study.
    PLoS One. 2017;12:e0171154.
    PubMed     Text format     Abstract available


  29. AZIZ S, Wik E, Knutsvik G, Klingen TA, et al
    Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer.
    PLoS One. 2017;12:e0171853.
    PubMed     Text format     Abstract available


  30. GOMES-ROCHETTE NF, Souza LS, Tommasi BO, Pedrosa DF, et al
    Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence.
    PLoS One. 2017;12:e0169266.
    PubMed     Text format     Abstract available


  31. AUGUSTE A, Cortet M, Dabakuyo-Yonli TS, Launay L, et al
    Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study.
    PLoS One. 2017;12:e0170069.
    PubMed     Text format     Abstract available


  32. HUANG NS, Quan CL, Mo M, Chen JJ, et al
    A prospective study of breast anthropomorphic measurements, volume and ptosis in 605 Asian patients with breast cancer or benign breast disease.
    PLoS One. 2017;12:e0172122.
    PubMed     Text format     Abstract available


  33. AKUOKO CP, Armah E, Sarpong T, Quansah DY, et al
    Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa.
    PLoS One. 2017;12:e0171024.
    PubMed     Text format     Abstract available


  34. TERRENATO I, D'Alicandro V, Casini B, Perracchio L, et al
    A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.
    PLoS One. 2017;12:e0171517.
    PubMed     Text format     Abstract available


  35. JANG MH, Kim HJ, Chung YR, Lee Y, et al
    A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method.
    PLoS One. 2017;12:e0172031.
    PubMed     Text format     Abstract available


  36. CONTE F, Fiscon G, Chiara M, Colombo T, et al
    Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    PLoS One. 2017;12:e0171661.
    PubMed     Text format     Abstract available


  37. KASHIWAGI S, Asano Y, Goto W, Takada K, et al
    Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.
    PLoS One. 2017;12:e0170634.
    PubMed     Text format     Abstract available


  38. FAN M, Li H, Wang S, Zheng B, et al
    Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.
    PLoS One. 2017;12:e0171683.
    PubMed     Text format     Abstract available


  39. TAKEDA T, Yamamoto H, Kanzaki H, Suzawa K, et al
    Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
    PLoS One. 2017;12:e0171356.
    PubMed     Text format     Abstract available


  40. SIEUWERTS AM, Schrijver WA, Dalm SU, de Weerd V, et al
    Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    PLoS One. 2017;12:e0171343.
    PubMed     Text format     Abstract available


  41. QIAN XL, Zhang J, Li PZ, Lang RG, et al
    Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP).
    PLoS One. 2017;12:e0171169.
    PubMed     Text format     Abstract available


  42. QIAO W, Pan L, Kou C, Li K, et al
    Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0172413.
    PubMed     Text format     Abstract available


  43. KIM MH, Lee KY, Park S, Kim SI, et al
    Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trial.
    PLoS One. 2017;12:e0173026.
    PubMed     Text format     Abstract available


  44. GSCHWANTLER-KAULICH D, Tan YY, Fuchs EM, Hudelist G, et al
    PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer.
    PLoS One. 2017;12:e0172911.
    PubMed     Text format     Abstract available


  45. CLARKE CS, Hunter RM, Shemilt I, Serra-Sastre V, et al
    Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective.
    PLoS One. 2017;12:e0172731.
    PubMed     Text format     Abstract available


  46. CHUNG IY, Lee JW, Lee JS, Park YR, et al
    Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
    PLoS One. 2017;12:e0170311.
    PubMed     Text format     Abstract available


  47. KAN-DAPAAH K, Rahbar N, Soboyejo W
    Polymeric composite devices for localized treatment of early-stage breast cancer.
    PLoS One. 2017;12:e0172542.
    PubMed     Text format     Abstract available


  48. ISLAM S, Dasgupta H, Roychowdhury A, Bhattacharya R, et al
    Study of association and molecular analysis of human papillomavirus in breast cancer of Indian patients: Clinical and prognostic implication.
    PLoS One. 2017;12:e0172760.
    PubMed     Text format     Abstract available


  49. SIMON M, Mesmar F, Helguero L, Williams C, et al
    Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant.
    PLoS One. 2017;12:e0172832.
    PubMed     Text format     Abstract available


  50. PAN Y, Yuan Y, Liu G, Wei Y, et al
    P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
    PLoS One. 2017;12:e0172324.
    PubMed     Text format     Abstract available


  51. CURRY A, Khatri I, Kos O, Zhu F, et al
    Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.
    PLoS One. 2017;12:e0171586.
    PubMed     Text format     Abstract available


  52. LEE J, Kim HH, Ro SM, Yang JH, et al
    Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer.
    PLoS One. 2017;12:e0171605.
    PubMed     Text format     Abstract available


  53. SON SH, Choi KH, Kim SW
    Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer.
    PLoS One. 2017;12:e0173552.
    PubMed     Text format     Abstract available


  54. MENNING S, de Ruiter MB, Veltman DJ, Boogerd W, et al
    Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.
    PLoS One. 2017;12:e0171724.
    PubMed     Text format     Abstract available


  55. ZAK M, Biskup M, Macek P, Krol H, et al
    Identifying predictive motor factors for falls in post-menopausal breast cancer survivors.
    PLoS One. 2017;12:e0173970.
    PubMed     Text format     Abstract available


  56. TOSCANI AM, Sampayo RG, Barabas FM, Fuentes F, et al
    Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models.
    PLoS One. 2017;12:e0174230.
    PubMed     Text format     Abstract available



  57. Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
    PLoS One. 2017;12:e0174493.
    PubMed     Text format     Abstract available


  58. HENG J, Guo X, Wu W, Wang Y, et al
    Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients.
    PLoS One. 2017;12:e0174022.
    PubMed     Text format     Abstract available


  59. HE X, Ye F, Zhao B, Tang H, et al
    Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients.
    PLoS One. 2017;12:e0173862.
    PubMed     Text format     Abstract available


  60. KLEBANER D, Hamilton-Dutoit S, Ahern T, Crawford A, et al
    Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.
    PLoS One. 2017;12:e0171453.
    PubMed     Text format     Abstract available


  61. NG CG, Mohamed S, Kaur K, Sulaiman AH, et al
    Perceived distress and its association with depression and anxiety in breast cancer patients.
    PLoS One. 2017;12:e0172975.
    PubMed     Text format     Abstract available


  62. LIU Y, Gu F, Liang J, Dai X, et al
    The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0173693.
    PubMed     Text format     Abstract available


  63. AZAD AK, Lawen A, Keith JM
    Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer.
    PLoS One. 2017;12:e0173331.
    PubMed     Text format     Abstract available


  64. SHEN CJ, Kuo YL, Chen CC, Chen MJ, et al
    MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer.
    PLoS One. 2017;12:e0174487.
    PubMed     Text format     Abstract available


  65. LEE J, Hong BS, Ryu HS, Lee HB, et al
    Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism.
    PLoS One. 2017;12:e0174126.
    PubMed     Text format     Abstract available


  66. CHANG YW, Singh KP
    Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    PLoS One. 2017;12:e0174227.
    PubMed     Text format     Abstract available


  67. HAN J, Lee HB, Lee ES, Kang YJ, et al
    The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities.
    PLoS One. 2017;12:e0173721.
    PubMed     Text format     Abstract available


  68. ZHANG N, Fielding R, Soong I, Chan KK, et al
    Psychometric assessment of the Chinese version of the brief illness perception questionnaire in breast cancer survivors.
    PLoS One. 2017;12:e0174093.
    PubMed     Text format     Abstract available


  69. STANKEVICINS L, Barat A, Dessen P, Vassetzky Y, et al
    The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model.
    PLoS One. 2017;12:e0173756.
    PubMed     Text format     Abstract available


  70. GUIMARAES E, Machado R, Fonseca MC, Franca A, et al
    Inositol 1, 4, 5-trisphosphate-dependent nuclear calcium signals regulate angiogenesis and cell motility in triple negative breast cancer.
    PLoS One. 2017;12:e0175041.
    PubMed     Text format     Abstract available


  71. ZHAO M, Howard EW, Guo Z, Parris AB, et al
    p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells.
    PLoS One. 2017;12:e0175121.
    PubMed     Text format     Abstract available


  72. FANG S, Tian H, Li X, Jin D, et al
    Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification.
    PLoS One. 2017;12:e0175050.
    PubMed     Text format     Abstract available



  73. Retraction: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells.
    PLoS One. 2017;12:e0175772.
    PubMed     Text format    



  74. Retraction: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells.
    PLoS One. 2017;12:e0175869.
    PubMed     Text format    


  75. KIM MS, Kim SY, Kim JH, Park B, et al
    Depression in breast cancer patients who have undergone mastectomy: A national cohort study.
    PLoS One. 2017;12:e0175395.
    PubMed     Text format     Abstract available


  76. GUO Y, Yu P, Liu Z, Maimaiti Y, et al
    Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0174843.
    PubMed     Text format     Abstract available


  77. EL GUERRAB A, Cayre A, Kwiatkowski F, Privat M, et al
    Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer.
    PLoS One. 2017;12:e0175960.
    PubMed     Text format     Abstract available


  78. TIRAN V, Stanzer S, Heitzer E, Meilinger M, et al
    Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    PLoS One. 2017;12:e0175223.
    PubMed     Text format     Abstract available


  79. CASTLE J, Morris K, Pritchard S, Kirwan CC, et al
    Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.
    PLoS One. 2017;12:e0175647.
    PubMed     Text format     Abstract available


  80. AHN SG, Lee JH, Lee HW, Jeon TJ, et al
    Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
    PLoS One. 2017;12:e0175048.
    PubMed     Text format     Abstract available


  81. GRONBERG M, Ahlin C, Naeser Y, Janson ET, et al
    Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer.
    PLoS One. 2017;12:e0176059.
    PubMed     Text format     Abstract available


  82. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2017;12:e0175323.
    PubMed     Text format     Abstract available


  83. BOYD A, Stoodley P, Richards D, Hui R, et al
    Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
    PLoS One. 2017;12:e0175544.
    PubMed     Text format     Abstract available


    January 2016
  84. GROTTKE A, Ewald F, Lange T, Norz D, et al
    Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    PLoS One. 2016;11:e0146370.
    PubMed     Text format     Abstract available


  85. GSCHWANTLER-KAULICH D, Grunt TW, Muhr D, Wagner R, et al
    HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK.
    PLoS One. 2016;11:e0146311.
    PubMed     Text format     Abstract available


  86. CHEN QW, Li HJ, Chen YN, Ning ZY, et al
    Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0139782.
    PubMed     Text format     Abstract available


  87. NALWOGA H, Ahmed L, Arnes JB, Wabinga H, et al
    Strong Expression of Hypoxia-Inducible Factor-1alpha (HIF-1alpha) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.
    PLoS One. 2016;11:e0146823.
    PubMed     Text format     Abstract available


  88. RAGHAV K, French JT, Ueno NT, Lei X, et al
    Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction.
    PLoS One. 2016;11:e0145534.
    PubMed     Text format     Abstract available


  89. GUAN F, Ding Y, Zhang Y, Zhou Y, et al
    Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation.
    PLoS One. 2016;11:e0146553.
    PubMed     Text format     Abstract available


  90. OLIVEIRA SF, Ganzinelli M, Chila R, Serino L, et al
    Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
    PLoS One. 2016;11:e0145647.
    PubMed     Text format     Abstract available


  91. DVORTSIN E, Gout-Zwart J, Eijssen EM, van Brussel J, et al
    Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer.
    PLoS One. 2016;11:e0146551.
    PubMed     Text format     Abstract available


  92. MEI Y, Zhao S, Lu X, Liu H, et al
    Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer.
    PLoS One. 2016;11:e0146233.
    PubMed     Text format     Abstract available


  93. HSIEH CC, Huang YS
    Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production.
    PLoS One. 2016;11:e0147161.
    PubMed     Text format     Abstract available


  94. MINATANI N, Waraya M, Yamashita K, Kikuchi M, et al
    Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.
    PLoS One. 2016;11:e0144862.
    PubMed     Text format     Abstract available


  95. BOUGHORBEL S, Al-Ali R, Elkum N
    Model Comparison for Breast Cancer Prognosis Based on Clinical Data.
    PLoS One. 2016;11:e0146413.
    PubMed     Text format     Abstract available


  96. SCHUMMER M, Thorpe J, Giraldez MD, Bergan L, et al
    Correction: Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
    PLoS One. 2016;11:e0147561.
    PubMed     Text format     Abstract available


  97. OULDAMER L, Goupille C, Vilde A, Arbion F, et al
    N-3 Polyunsaturated Fatty Acids of Marine Origin and Multifocality in Human Breast Cancer.
    PLoS One. 2016;11:e0147148.
    PubMed     Text format     Abstract available


  98. CHANG TH, Hsu HH, Chou YC, Yu JC, et al
    Correction: The Values of Combined and Sub-Stratified Imaging Scores with Ultrasonography and Mammography in Breast Cancer Subtypes.
    PLoS One. 2016;11:e0148005.
    PubMed     Text format     Abstract available


  99. FEI X, Lou Z, Christakos G, Liu Q, et al
    A Geographic Analysis about the Spatiotemporal Pattern of Breast Cancer in Hangzhou from 2008 to 2012.
    PLoS One. 2016;11:e0147866.
    PubMed     Text format     Abstract available


  100. NEMESCU D, Ursu RG, Nemescu ER, Negura L, et al
    Heterogeneous Distribution of Fetal Microchimerism in Local Breast Cancer Environment.
    PLoS One. 2016;11:e0147675.
    PubMed     Text format     Abstract available


  101. SHARMA M, Tuaine J, McLaren B, Waters DL, et al
    Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells.
    PLoS One. 2016;11:e0148049.
    PubMed     Text format     Abstract available


  102. HO JY, Chang FW, Huang FS, Liu JM, et al
    Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERalpha-DeltaNp63-Integrin beta4 Signaling Pathway.
    PLoS One. 2016;11:e0148301.
    PubMed     Text format     Abstract available


  103. KAWIAK A, Lojkowska E
    Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells.
    PLoS One. 2016;11:e0147718.
    PubMed     Text format     Abstract available


  104. MOUTTET D, Lae M, Caly M, Gentien D, et al
    Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant Microarray Based Assay.
    PLoS One. 2016;11:e0146474.
    PubMed     Text format     Abstract available


  105. PREYER O, Johansen D, Holly J, Stocks T, et al
    gamma-Glutamyltransferase and Breast Cancer Risk Beyond Alcohol Consumption and Other Life Style Factors - A Pooled Cohort Analysis.
    PLoS One. 2016;11:e0149122.
    PubMed     Text format     Abstract available


  106. FRIED S, Tosun S, Troost G, Keil S, et al
    Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial x Breast Cancer Hybrids, but Not in Parental Cells.
    PLoS One. 2016;11:e0148438.
    PubMed     Text format     Abstract available


  107. LEE HH, Hou MF, Wei SY, Lin SD, et al
    Comparison of Long-Term Outcomes of Postmastectomy Radiotherapy between Breast Cancer Patients with and without Immediate Flap Reconstruction.
    PLoS One. 2016;11:e0148318.
    PubMed     Text format     Abstract available


  108. SCHNECK H, Gierke B, Uppenkamp F, Behrens B, et al
    Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    PLoS One. 2016;11:e0149315.
    PubMed     Text format     Abstract available


  109. BOULDING T, Wu F, McCuaig R, Dunn J, et al
    Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer.
    PLoS One. 2016;11:e0148065.
    PubMed     Text format     Abstract available


  110. LEE CS, Taib NA, Ashrafzadeh A, Fadzli F, et al
    Unmasking Heavily O-Glycosylated Serum Proteins Using Perchloric Acid: Identification of Serum Proteoglycan 4 and Protease C1 Inhibitor as Molecular Indicators for Screening of Breast Cancer.
    PLoS One. 2016;11:e0149551.
    PubMed     Text format     Abstract available


  111. LO WC, Li W, Jones EF, Newitt DC, et al
    Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes.
    PLoS One. 2016;11:e0142047.
    PubMed     Text format     Abstract available


  112. LIU L, Tong Q, Liu S, Cui J, et al
    ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer.
    PLoS One. 2016;11:e0148774.
    PubMed     Text format     Abstract available


  113. LEE WJ, Kim SC, Yoon JH, Yoon SJ, et al
    Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis.
    PLoS One. 2016;11:e0148818.
    PubMed     Text format     Abstract available


  114. XUE C, Peng R, Cao Y, Wang S, et al
    Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer.
    PLoS One. 2016;11:e0148849.
    PubMed     Text format     Abstract available


  115. PARK S, Yoon JH, Sohn J, Park HS, et al
    Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.
    PLoS One. 2016;11:e0149347.
    PubMed     Text format     Abstract available


  116. LEE JY, Lim SH, Lee MY, Kim HS, et al
    The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).
    PLoS One. 2016;11:e0149432.
    PubMed     Text format     Abstract available


  117. HUNG MH, Liu CJ, Teng CJ, Hu YW, et al
    Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study.
    PLoS One. 2016;11:e0148597.
    PubMed     Text format     Abstract available


  118. YUE Y, Astvatsaturyan K, Cui X, Zhang X, et al
    Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
    PLoS One. 2016;11:e0149661.
    PubMed     Text format     Abstract available


  119. ZHONG F, Bi R, Yu B, Yang F, et al
    A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
    PLoS One. 2016;11:e0150505.
    PubMed     Text format     Abstract available


  120. HAN C, Yang B, Zuo WS, Zheng G, et al
    The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
    PLoS One. 2016;11:e0150285.
    PubMed     Text format     Abstract available


  121. COOKE GE, Wetter NC, Banducci SE, Mackenzie MJ, et al
    Moderate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer Survivors.
    PLoS One. 2016;11:e0149552.
    PubMed     Text format     Abstract available


  122. RENZI C, Vadilonga V, Gandini S, Perinel G, et al
    Stress Exposure in Significant Relationships Is Associated with Lymph Node Status in Breast Cancer.
    PLoS One. 2016;11:e0149443.
    PubMed     Text format     Abstract available


  123. YANG YH, Buhamrah A, Schneider A, Lin YL, et al
    Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer.
    PLoS One. 2016;11:e0150151.
    PubMed     Text format     Abstract available


  124. ALKNER S, Bendahl PO, Ehinger A, Lovgren K, et al
    Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.
    PLoS One. 2016;11:e0150977.
    PubMed     Text format     Abstract available


  125. SMITH TA, Phyu SM
    Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells.
    PLoS One. 2016;11:e0151179.
    PubMed     Text format     Abstract available


  126. DROLEZ A, Vandenhaute E, Julien S, Gosselet F, et al
    Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines.
    PLoS One. 2016;11:e0151155.
    PubMed     Text format     Abstract available


  127. AZIZ S, Wik E, Knutsvik G, Klingen TA, et al
    Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.
    PLoS One. 2016;11:e0150979.
    PubMed     Text format     Abstract available


  128. MCAULIFFE PF, Evans KW, Akcakanat A, Chen K, et al
    Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
    PLoS One. 2016;11:e0151121.
    PubMed     Text format     Abstract available


  129. WU YY, Huang TC, Tsai TN, Chen JH, et al
    The Clinical Efficacy and Cardiotoxicity of Fixed-Dose Monthly Trastuzumab in HER2-Positive Breast Cancer: A Single Institutional Analysis.
    PLoS One. 2016;11:e0151112.
    PubMed     Text format     Abstract available


  130. LAI HW, Chen ST, Chen DR, Chen SL, et al
    Current Trends in and Indications for Endoscopy-Assisted Breast Surgery for Breast Cancer: Results from a Six-Year Study Conducted by the Taiwan Endoscopic Breast Surgery Cooperative Group.
    PLoS One. 2016;11:e0150310.
    PubMed     Text format     Abstract available


  131. VALLET S, Bashari MH, Fan FJ, Malvestiti S, et al
    Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET Pathway.
    PLoS One. 2016;11:e0150507.
    PubMed     Text format     Abstract available


  132. GONCALVES NDO N, Colombo J, Lopes JR, Gelaleti GB, et al
    Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
    PLoS One. 2016;11:e0150407.
    PubMed     Text format     Abstract available


  133. BERKEMEYER S, Lemke D, Hense HW
    Incidence and Mortality Trends in German Women with Breast Cancer Using Age, Period and Cohort 1999 to 2008.
    PLoS One. 2016;11:e0150723.
    PubMed     Text format     Abstract available


  134. BECKER MA, Ibrahim YH, Oh AS, Fagan DH, et al
    Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer.
    PLoS One. 2016;11:e0150564.
    PubMed     Text format     Abstract available


  135. NAIR HB, Santhamma B, Krishnegowda NK, Dileep KV, et al
    Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.
    PLoS One. 2016;11:e0151182.
    PubMed     Text format     Abstract available


  136. GHANOUNI A, Meisel SF, Hersch J, Waller J, et al
    Information on 'Overdiagnosis' in Breast Cancer Screening on Prominent United Kingdom- and Australia-Oriented Health Websites.
    PLoS One. 2016;11:e0152279.
    PubMed     Text format     Abstract available


  137. RIZK SM, Shahin NN, Shaker OG
    Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians.
    PLoS One. 2016;11:e0151901.
    PubMed     Text format     Abstract available


  138. MATTA J, Morales L, Ortiz C, Adams D, et al
    Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer.
    PLoS One. 2016;11:e0152422.
    PubMed     Text format     Abstract available


  139. WANG K, Ren Y, Li H, Zheng K, et al
    Comparison of Clinicopathological Features and Treatments between Young (</=40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study.
    PLoS One. 2016;11:e0152312.
    PubMed     Text format     Abstract available


  140. CHAE YK, Gagliato DM, Pai SG, Carneiro B, et al
    The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
    PLoS One. 2016;11:e0152585.
    PubMed     Text format     Abstract available


  141. TIN TIN S, Elwood JM, Lawrenson R, Campbell I, et al
    Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?
    PLoS One. 2016;11:e0153206.
    PubMed     Text format     Abstract available


  142. BILLARD MJ, Fitzhugh DJ, Parker JS, Brozowski JM, et al
    G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis.
    PLoS One. 2016;11:e0152856.
    PubMed     Text format     Abstract available


  143. PHELPS-POLIRER K, Abt MA, Smith D, Yeh ES, et al
    Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer.
    PLoS One. 2016;11:e0153025.
    PubMed     Text format     Abstract available


  144. ZHANG X, Zhong S, Xu Y, Yu D, et al
    MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3beta/beta-Catenin Signaling Pathway.
    PLoS One. 2016;11:e0153194.
    PubMed     Text format     Abstract available


  145. AHIRWAR R, Vellarikkal SK, Sett A, Sivasubbu S, et al
    Aptamer-Assisted Detection of the Altered Expression of Estrogen Receptor Alpha in Human Breast Cancer.
    PLoS One. 2016;11:e0153001.
    PubMed     Text format     Abstract available


  146. YAN B, Yang LM, Hao LP, Yang C, et al
    Determinants of Quality of Life for Breast Cancer Patients in Shanghai, China.
    PLoS One. 2016;11:e0153714.
    PubMed     Text format     Abstract available


  147. WEINGAERTNER IR, Koutnik S, Ammer H
    Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network.
    PLoS One. 2016;11:e0153824.
    PubMed     Text format     Abstract available


  148. HAO W, Friedman A
    Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.
    PLoS One. 2016;11:e0153508.
    PubMed     Text format     Abstract available


  149. KORLIMARLA A, Prabhu JS, Remacle J, Rajarajan S, et al
    Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0153113.
    PubMed     Text format     Abstract available


  150. MAO Y, Qu Q, Chen X, Huang O, et al
    The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0152500.
    PubMed     Text format     Abstract available


  151. LI T, Zhao J, Yang J, Ma X, et al
    A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    PLoS One. 2016;11:e0153314.
    PubMed     Text format     Abstract available


  152. AL-KHANBASHI M, Caramuta S, Alajmi AM, Al-Haddabi I, et al
    Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.
    PLoS One. 2016;11:e0152032.
    PubMed     Text format     Abstract available


  153. RASOULZADEH Z, Ghods R, Kazemi T, Mirzadegan E, et al
    Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells.
    PLoS One. 2016;11:e0153684.
    PubMed     Text format     Abstract available


  154. AUTIER P, Boniol M, Smans M, Sullivan R, et al
    Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening.
    PLoS One. 2016;11:e0154113.
    PubMed     Text format     Abstract available


  155. MOHAN CD, Srinivasa V, Rangappa S, Mervin L, et al
    Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway.
    PLoS One. 2016;11:e0153155.
    PubMed     Text format     Abstract available


  156. MIQUEL-CASES A, Retel VP, Lederer B, von Minckwitz G, et al
    Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients.
    PLoS One. 2016;11:e0154386.
    PubMed     Text format     Abstract available


  157. ZHANG P, Yang X, Yin Q, Yi J, et al
    Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.
    PLoS One. 2016;11:e0154471.
    PubMed     Text format     Abstract available


  158. TENORIO MJ, Ross BH, Luchsinger C, Rivera-Dictter A, et al
    Distinct Biochemical Pools of Golgi Phosphoprotein 3 in the Human Breast Cancer Cell Lines MCF7 and MDA-MB-231.
    PLoS One. 2016;11:e0154719.
    PubMed     Text format     Abstract available


  159. FIOCCHETTI M, Cipolletti M, Leone S, Naldini A, et al
    Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function.
    PLoS One. 2016;11:e0154959.
    PubMed     Text format     Abstract available


  160. HSIEH JC, Cramb SM, McGree JM, Dunn NA, et al
    Spatially Varying Coefficient Inequalities: Evaluating How the Impact of Patient Characteristics on Breast Cancer Survival Varies by Location.
    PLoS One. 2016;11:e0155086.
    PubMed     Text format     Abstract available


  161. PELTTARI LM, Khan S, Vuorela M, Kiiski JI, et al
    RAD51B in Familial Breast Cancer.
    PLoS One. 2016;11:e0153788.
    PubMed     Text format     Abstract available


  162. MENNIE JC, Mohanna PN, O'Donoghue JM, Rainsbury R, et al
    The Proportion of Women Who Have a Breast 4 Years after Breast Cancer Surgery: A Population-Based Cohort Study.
    PLoS One. 2016;11:e0153704.
    PubMed     Text format     Abstract available


  163. RAJH M, Dolinar K, Mis K, Pavlin M, et al
    Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells.
    PLoS One. 2016;11:e0154747.
    PubMed     Text format     Abstract available


  164. BALAJI SA, Udupa N, Chamallamudi MR, Gupta V, et al
    Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance.
    PLoS One. 2016;11:e0155013.
    PubMed     Text format     Abstract available


  165. APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
    Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    PLoS One. 2016;11:e0155262.
    PubMed     Text format     Abstract available


  166. KALA R, Tollefsbol TO
    A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-alpha (ERalpha) Expression in ERalpha-Negative Breast Cancer Cells.
    PLoS One. 2016;11:e0155057.
    PubMed     Text format     Abstract available


  167. YANG J, Niu H, Huang Y, Yang K, et al
    A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
    PLoS One. 2016;11:e0149185.
    PubMed     Text format     Abstract available


  168. BASTOS EP, Brentani H, Pereira CA, Polpo A, et al
    A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
    PLoS One. 2016;11:e0154325.
    PubMed     Text format     Abstract available


  169. WON HS, Lee KM, Oh JE, Nam EM, et al
    Inhibition of beta-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line.
    PLoS One. 2016;11:e0155983.
    PubMed     Text format     Abstract available


  170. LEI L, Yu X, Chen B, Chen Z, et al
    Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
    PLoS One. 2016;11:e0155132.
    PubMed     Text format     Abstract available


  171. HIGUCHI T, Endo M, Hanamura T, Gohno T, et al
    Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer.
    PLoS One. 2016;11:e0155844.
    PubMed     Text format     Abstract available


  172. GUO Y, Yu P, Liu Z, Maimaiti Y, et al
    Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0156323.
    PubMed     Text format     Abstract available


  173. GORI S, Inno A, Rossi V, Turazza M, et al
    Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.
    PLoS One. 2016;11:e0156221.
    PubMed     Text format     Abstract available


  174. SOPRANO M, Sorriento D, Rusciano MR, Maione AS, et al
    Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells.
    PLoS One. 2016;11:e0155970.
    PubMed     Text format     Abstract available


  175. ZHANG X, Li Y, Zhou Y, Mao F, et al
    Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0155597.
    PubMed     Text format     Abstract available


  176. CHEREAU E, Uzan C, Boutmy-Deslandes E, Zohar S, et al
    Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study.
    PLoS One. 2016;11:e0156096.
    PubMed     Text format     Abstract available


  177. RENAULT AL, Lesueur F, Coulombe Y, Gobeil S, et al
    ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
    PLoS One. 2016;11:e0156820.
    PubMed     Text format     Abstract available


  178. ZHONG X, Dong Z, Dong H, Li J, et al
    Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
    PLoS One. 2016;11:e0156789.
    PubMed     Text format     Abstract available


  179. LEHMANN BD, Jovanovic B, Chen X, Estrada MV, et al
    Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
    PLoS One. 2016;11:e0157368.
    PubMed     Text format     Abstract available


  180. CUSTODIO ID, Marinho ED, Gontijo CA, Pereira TS, et al
    Impact of Chemotherapy on Diet and Nutritional Status of Women with Breast Cancer: A Prospective Study.
    PLoS One. 2016;11:e0157113.
    PubMed     Text format     Abstract available


  181. GUEST SK, Ribas R, Pancholi S, Nikitorowicz-Buniak J, et al
    Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
    PLoS One. 2016;11:e0157397.
    PubMed     Text format     Abstract available


  182. ROBERTS GC, Morris PG, Moss MA, Maltby SL, et al
    An Evaluation of Matrix-Containing and Humanised Matrix-Free 3-Dimensional Cell Culture Systems for Studying Breast Cancer.
    PLoS One. 2016;11:e0157004.
    PubMed     Text format     Abstract available


  183. LI Y, Wu Q, Li C, Liu L, et al
    Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
    PLoS One. 2016;11:e0157576.
    PubMed     Text format     Abstract available


  184. LI J, Liu Y, Jiang Y, Shao Z, et al
    Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods.
    PLoS One. 2016;11:e0157322.
    PubMed     Text format     Abstract available


  185. WULANINGSIH W, Holmberg L, Abeler-Doner L, Ng T, et al
    Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
    PLoS One. 2016;11:e0157482.
    PubMed     Text format     Abstract available


  186. RIVERA RIVERA A, Castillo-Pichardo L, Gerena Y, Dharmawardhane S, et al
    Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
    PLoS One. 2016;11:e0157251.
    PubMed     Text format     Abstract available


  187. ZHOU Y, Wang C, Zhu H, Lin Y, et al
    Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
    PLoS One. 2016;11:e0158143.
    PubMed     Text format     Abstract available


  188. TANG Z, Wang J, Zhang H, Sun L, et al
    Associations between Diabetes and Quality of Life among Breast Cancer Survivors.
    PLoS One. 2016;11:e0157791.
    PubMed     Text format     Abstract available


  189. VALLEGA KA, Liu N, Myers JS, Yu K, et al
    Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
    PLoS One. 2016;11:e0157741.
    PubMed     Text format     Abstract available


  190. PAEZ-RIBES M, Man S, Xu P, Kerbel RS, et al
    Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    PLoS One. 2016;11:e0158034.
    PubMed     Text format     Abstract available


  191. ZIEGLER YS, Moresco JJ, Yates JR 3rd, Nardulli AM, et al
    Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.
    PLoS One. 2016;11:e0158296.
    PubMed     Text format     Abstract available


  192. MEDINA-AGUILAR R, Perez-Plasencia C, Marchat LA, Gariglio P, et al
    Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol.
    PLoS One. 2016;11:e0157866.
    PubMed     Text format     Abstract available


  193. DORLING L, Kar S, Michailidou K, Hiller L, et al
    The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study.
    PLoS One. 2016;11:e0158984.
    PubMed     Text format     Abstract available


  194. DIAS JA, Fredrikson GN, Ericson U, Gullberg B, et al
    Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmo Diet and Cancer Cohort.
    PLoS One. 2016;11:e0158959.
    PubMed     Text format     Abstract available


  195. KOO HY, Seo YG, Cho MH, Kim MJ, et al
    Weight Change and Associated Factors in Long-Term Breast Cancer Survivors.
    PLoS One. 2016;11:e0159098.
    PubMed     Text format     Abstract available


  196. HU K, Lou L, Tian W, Pan T, et al
    The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment.
    PLoS One. 2016;11:e0158951.
    PubMed     Text format     Abstract available


  197. SINGH B, Kinne HE, Milligan RD, Washburn LJ, et al
    Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge.
    PLoS One. 2016;11:e0159072.
    PubMed     Text format     Abstract available


  198. VALLERAND D, Massonnet G, Kebir F, Gentien D, et al
    Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization.
    PLoS One. 2016;11:e0157670.
    PubMed     Text format     Abstract available


  199. BONSANG-KITZIS H, Chaltier L, Belin L, Savignoni A, et al
    Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
    PLoS One. 2016;11:e0159123.
    PubMed     Text format     Abstract available


  200. CHOI HY, Ko ES, Han BK, Kim EJ, et al
    Prognostic Significance of Transverse Relaxation Rate (R2*) in Blood Oxygenation Level-Dependent Magnetic Resonance Imaging in Patients with Invasive Breast Cancer.
    PLoS One. 2016;11:e0158500.
    PubMed     Text format     Abstract available


  201. BENNANI-BAITI B, Dietzel M, Baltzer PA
    MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    PLoS One. 2016;11:e0158573.
    PubMed     Text format     Abstract available


  202. CARRIER M, Joint M, Lutzing R, Page A, et al
    Phosphoproteome and Transcriptome of RA-Responsive and RA-Resistant Breast Cancer Cell Lines.
    PLoS One. 2016;11:e0157290.
    PubMed     Text format     Abstract available


  203. CHAE EY, Moon WK, Kim HH, Kim WH, et al
    Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer.
    PLoS One. 2016;11:e0158461.
    PubMed     Text format     Abstract available


  204. MA Y, Yin F, Zhang T, Zhou XA, et al
    Selection of the Maximum Spatial Cluster Size of the Spatial Scan Statistic by Using the Maximum Clustering Set-Proportion Statistic.
    PLoS One. 2016;11:e0147918.
    PubMed     Text format     Abstract available


  205. GOGOI P, Sepehri S, Zhou Y, Gorin MA, et al
    Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.
    PLoS One. 2016;11:e0147400.
    PubMed     Text format     Abstract available


  206. MARVIBAIGI M, Amini N, Supriyanto E, Abdul Majid FA, et al
    Antioxidant Activity and ROS-Dependent Apoptotic Effect of Scurrula ferruginea (Jack) Danser Methanol Extract in Human Breast Cancer Cell MDA-MB-231.
    PLoS One. 2016;11:e0158942.
    PubMed     Text format     Abstract available


  207. YU C, Wang J
    A Physical Mechanism and Global Quantification of Breast Cancer.
    PLoS One. 2016;11:e0157422.
    PubMed     Text format     Abstract available


  208. THAKUR S, Grover RK, Gupta S, Yadav AK, et al
    Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0158946.
    PubMed     Text format     Abstract available


  209. KLOTEN V, Schlensog M, Eschenbruch J, Gasthaus J, et al
    Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
    PLoS One. 2016;11:e0159073.
    PubMed     Text format     Abstract available


  210. BAUR B, Bozdag S
    A Feature Selection Algorithm to Compute Gene Centric Methylation from Probe Level Methylation Data.
    PLoS One. 2016;11:e0148977.
    PubMed     Text format     Abstract available


  211. DEVLIN KL, Sanford T, Harrison LM, LeBourgeois P, et al
    Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer.
    PLoS One. 2016;11:e0159686.
    PubMed     Text format     Abstract available


  212. QIU J, Guan J, Yang X, Wu J, et al
    Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic Testing.
    PLoS One. 2016;11:e0158531.
    PubMed     Text format     Abstract available


  213. PEREZ-PEREZ A, Sanchez-Jimenez F, Vilarino-Garcia T, de la Cruz L, et al
    Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells.
    PLoS One. 2016;11:e0158218.
    PubMed     Text format     Abstract available


  214. ONER C, Turgut Cosan D, Colak E
    Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer.
    PLoS One. 2016;11:e0159044.
    PubMed     Text format     Abstract available


  215. TAVAKOLI TABA S, Hossain L, Heard R, Brennan P, et al
    Personal and Network Dynamics in Performance of Knowledge Workers: A Study of Australian Breast Radiologists.
    PLoS One. 2016;11:e0150186.
    PubMed     Text format     Abstract available


  216. MU WJ, Zhong WJ, Yao JY, Li LJ, et al
    Ultrasonic Elastography Research Based on a Multicenter Study: Adding Strain Ratio after 5-Point Scoring Evaluation or Not.
    PLoS One. 2016;11:e0148330.
    PubMed     Text format     Abstract available


  217. ASANO Y, Kashiwagi S, Onoda N, Noda S, et al
    Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer.
    PLoS One. 2016;11:e0153459.
    PubMed     Text format     Abstract available


  218. HE S, Wang M, Yang Z, Zhang J, et al
    Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.
    PLoS One. 2016;11:e0159916.
    PubMed     Text format     Abstract available


  219. LORSY E, Topuz AS, Geisler C, Stahl S, et al
    Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer.
    PLoS One. 2016;11:e0160077.
    PubMed     Text format     Abstract available


  220. STOCKER A, Hilbers ML, Gauthier C, Grogg J, et al
    HER2/CEP17 Ratios and Clinical Outcome in HER2-Positive Early Breast Cancer Undergoing Trastuzumab-Containing Therapy.
    PLoS One. 2016;11:e0159176.
    PubMed     Text format     Abstract available


  221. CHEN J, Yang C, Guo B, Sena ES, et al
    The Efficacy of Trastuzumab in Animal Models of Breast Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0158240.
    PubMed     Text format     Abstract available


  222. RIBE AR, Laurberg T, Laursen TM, Charles M, et al
    Ten-Year Mortality after a Breast Cancer Diagnosis in Women with Severe Mental Illness: A Danish Population-Based Cohort Study.
    PLoS One. 2016;11:e0158013.
    PubMed     Text format     Abstract available


  223. POSSO M, Carles M, Rue M, Puig T, et al
    Cost-Effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme.
    PLoS One. 2016;11:e0159806.
    PubMed     Text format     Abstract available


  224. YOON H, Yoon D, Yun M, Choi JS, et al
    Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI.
    PLoS One. 2016;11:e0159949.
    PubMed     Text format     Abstract available


  225. IGNATIADIS M, Zardavas D, Lemort M, Wilke C, et al
    Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.
    PLoS One. 2016;11:e0154009.
    PubMed     Text format     Abstract available


  226. TODOROVA VK, Makhoul I, Siegel ER, Wei J, et al
    Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
    PLoS One. 2016;11:e0160224.
    PubMed     Text format     Abstract available


  227. LINHER-MELVILLE K, Nashed MG, Ungard RG, Haftchenary S, et al
    Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
    PLoS One. 2016;11:e0161202.
    PubMed     Text format     Abstract available


  228. WULANINGSIH W, Holmberg L, Abeler-Dorner L, Ng T, et al
    Correction: Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
    PLoS One. 2016;11:e0161418.
    PubMed     Text format     Abstract available


  229. HENDERSON MC, Hollingsworth AB, Gordon K, Silver M, et al
    Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.
    PLoS One. 2016;11:e0157692.
    PubMed     Text format     Abstract available


  230. GOMEZ-ACEBO I, Dierssen-Sotos T, Palazuelos C, Perez-Gomez B, et al
    The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
    PLoS One. 2016;11:e0159672.
    PubMed     Text format     Abstract available


  231. CHEN X, Zhong SL, Lu P, Wang DD, et al
    miR-4443 Participates in the Malignancy of Breast Cancer.
    PLoS One. 2016;11:e0160780.
    PubMed     Text format     Abstract available


  232. LEDGER AE, Scurr ED, Hughes J, Macdonald A, et al
    Comparison of Dixon Sequences for Estimation of Percent Breast Fibroglandular Tissue.
    PLoS One. 2016;11:e0152152.
    PubMed     Text format     Abstract available


  233. KATAYAMA K, Narimatsu H
    Prediction of Female Breast Cancer Incidence among the Aging Society in Kanagawa, Japan.
    PLoS One. 2016;11:e0159913.
    PubMed     Text format     Abstract available


  234. FANI S, Dehghan F, Karimian H, Mun Lo K, et al
    Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/beta-Catenin Signaling Pathway.
    PLoS One. 2016;11:e0160836.
    PubMed     Text format     Abstract available


  235. VETA M, van Diest PJ, Jiwa M, Al-Janabi S, et al
    Mitosis Counting in Breast Cancer: Object-Level Interobserver Agreement and Comparison to an Automatic Method.
    PLoS One. 2016;11:e0161286.
    PubMed     Text format     Abstract available


  236. XU T, Le TD, Liu L, Wang R, et al
    Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data.
    PLoS One. 2016;11:e0152792.
    PubMed     Text format     Abstract available


  237. TELLAROLI P, Bazzi M, Donato M, Brazzale AR, et al
    Cross-Clustering: A Partial Clustering Algorithm with Automatic Estimation of the Number of Clusters.
    PLoS One. 2016;11:e0152333.
    PubMed     Text format     Abstract available


  238. KROIGARD AB, Thomassen M, Laenkholm AV, Kruse TA, et al
    Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
    PLoS One. 2016;11:e0151664.
    PubMed     Text format     Abstract available


  239. NYBAKKEN GE, Bala R, Gratzinger D, Jones CD, et al
    Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications.
    PLoS One. 2016;11:e0151735.
    PubMed     Text format     Abstract available


  240. GUTNIK L, Moses A, Stanley C, Tembo T, et al
    From Community Laywomen to Breast Health Workers: A Pilot Training Model to Implement Clinical Breast Exam Screening in Malawi.
    PLoS One. 2016;11:e0151389.
    PubMed     Text format     Abstract available


  241. KIM HS, Park S, Koo JS, Kim S, et al
    Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers.
    PLoS One. 2016;11:e0151054.
    PubMed     Text format     Abstract available


  242. SHERMAN ME, Ichikawa L, Pfeiffer RM, Miglioretti DL, et al
    Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients.
    PLoS One. 2016;11:e0160966.
    PubMed     Text format     Abstract available


  243. HORNE HN, Chung CC, Zhang H, Yu K, et al
    Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
    PLoS One. 2016;11:e0160316.
    PubMed     Text format     Abstract available


  244. LIU J, Sieuwerts AM, Look MP, van der Vlugt-Daane M, et al
    The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
    PLoS One. 2016;11:e0161731.
    PubMed     Text format     Abstract available


  245. SILVA VL, Ferreira D, Nobrega FL, Martins IM, et al
    Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0161290.
    PubMed     Text format     Abstract available


  246. MILLS D, Gomberawalla A, Gordon EJ, Tondre J, et al
    Examination of Duct Physiology in the Human Mammary Gland.
    PLoS One. 2016;11:e0150653.
    PubMed     Text format     Abstract available


  247. ZHANG W, Le TD, Liu L, Zhou ZH, et al
    Predicting miRNA Targets by Integrating Gene Regulatory Knowledge with Expression Profiles.
    PLoS One. 2016;11:e0152860.
    PubMed     Text format     Abstract available


  248. MOREL V, Joly D, Villatte C, Dubray C, et al
    Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients.
    PLoS One. 2016;11:e0152741.
    PubMed     Text format     Abstract available


  249. FISKAA T, Knutsen E, Nikolaisen MA, Jorgensen TE, et al
    Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines.
    PLoS One. 2016;11:e0161824.
    PubMed     Text format     Abstract available


  250. MA X, Wang X, Huang J, Chen Y, et al
    Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0160148.
    PubMed     Text format     Abstract available


  251. ENNOUR-IDRISSI K, Tetu B, Maunsell E, Poirier B, et al
    Association of Telomere Length with Breast Cancer Prognostic Factors.
    PLoS One. 2016;11:e0161903.
    PubMed     Text format     Abstract available


  252. NORTON N, Advani PP, Serie DJ, Geiger XJ, et al
    Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.
    PLoS One. 2016;11:e0153411.
    PubMed     Text format     Abstract available


  253. YANG SN, Li FJ, Chen JM, Zhang G, et al
    Kinetic Curve Type Assessment for Classification of Breast Lesions Using Dynamic Contrast-Enhanced MR Imaging.
    PLoS One. 2016;11:e0152827.
    PubMed     Text format     Abstract available


  254. CHAPA J, An G, Kulkarni SA
    Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model.
    PLoS One. 2016;11:e0152298.
    PubMed     Text format     Abstract available


  255. BENNANI-BAITI B, Dietzel M, Baltzer PA
    Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    PLoS One. 2016;11:e0162936.
    PubMed     Text format     Abstract available


  256. GENG C, Chen X, Pan X, Li J, et al
    The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node-Negative Breast Cancer after Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0162605.
    PubMed     Text format     Abstract available


  257. KIM HS, Jung M, Choi SK, Moon WK, et al
    Different Biological Action of Oleic Acid in ALDHhigh and ALDHlow Subpopulations Separated from Ductal Carcinoma In Situ of Breast Cancer.
    PLoS One. 2016;11:e0160835.
    PubMed     Text format     Abstract available


  258. SCHERER SD, Bauer J, Schmaus A, Neumaier C, et al
    TGF-beta1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT).
    PLoS One. 2016;11:e0162221.
    PubMed     Text format     Abstract available


  259. TANG S, Wei L, Sun Y, Zhou F, et al
    CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis.
    PLoS One. 2016;11:e0163030.
    PubMed     Text format     Abstract available


  260. VITALI F, Cohen LD, Demartini A, Amato A, et al
    A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0162407.
    PubMed     Text format     Abstract available


  261. WANG Q, Liu L, Li H, Tao P, et al
    Effects of High-Order Interactions among IGFBP-3 Genetic Polymorphisms, Body Mass Index and Soy Isoflavone Intake on Breast Cancer Susceptibility.
    PLoS One. 2016;11:e0162970.
    PubMed     Text format     Abstract available


  262. KRISHNAN P, Ghosh S, Wang B, Heyns M, et al
    Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis.
    PLoS One. 2016;11:e0162622.
    PubMed     Text format     Abstract available


  263. FUKADA I, Araki K, Kobayashi K, Shibayama T, et al
    Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.
    PLoS One. 2016;11:e0162616.
    PubMed     Text format     Abstract available


  264. FAN LC, Jeng YM, Lu YT, Lien HC, et al
    SPOCK1 Is a Novel Transforming Growth Factor-beta-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.
    PLoS One. 2016;11:e0162933.
    PubMed     Text format     Abstract available


  265. SUN X, Li Y, Zheng M, Zuo W, et al
    MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1.
    PLoS One. 2016;11:e0162754.
    PubMed     Text format     Abstract available


  266. BRADFORD JR, Cox A, Bernard P, Camp NJ, et al
    Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    PLoS One. 2016;11:e0163238.
    PubMed     Text format     Abstract available


  267. KOTOULA V, Lakis S, Vlachos IS, Giannoulatou E, et al
    Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.
    PLoS One. 2016;11:e0163138.
    PubMed     Text format     Abstract available


  268. PUCHALAPALLI M, Zeng X, Mu L, Anderson A, et al
    NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice.
    PLoS One. 2016;11:e0163521.
    PubMed     Text format     Abstract available


  269. ZHANG ZQ, Cao Z, Liu C, Li R, et al
    MiRNA-Embedded ShRNAs for Radiation-Inducible LGMN Knockdown and the Antitumor Effects on Breast Cancer.
    PLoS One. 2016;11:e0163446.
    PubMed     Text format     Abstract available


  270. LEE MH, Jung SY, Kang SH, Song EJ, et al
    The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients.
    PLoS One. 2016;11:e0163370.
    PubMed     Text format     Abstract available


  271. CHAE JW, Ng T, Yeo HL, Shwe M, et al
    Impact of TNF-alpha (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
    PLoS One. 2016;11:e0164204.
    PubMed     Text format     Abstract available


  272. STAVRIDI F, Kalogeras KT, Pliarchopoulou K, Wirtz RM, et al
    Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
    PLoS One. 2016;11:e0164013.
    PubMed     Text format     Abstract available


  273. KAWIAK A, Domachowska A
    Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKalpha-Mediated NF-kappaB Activation.
    PLoS One. 2016;11:e0164064.
    PubMed     Text format     Abstract available


  274. SAGARA A, Igarashi K, Otsuka M, Karasawa T, et al
    Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
    PLoS One. 2016;11:e0164250.
    PubMed     Text format     Abstract available


  275. HORIMOTO Y, Arakawa A, Sasahara N, Tanabe M, et al
    Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.
    PLoS One. 2016;11:e0165253.
    PubMed     Text format     Abstract available


  276. LIU X, Feng D, Liu D, Wang S, et al
    Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation.
    PLoS One. 2016;11:e0165001.
    PubMed     Text format     Abstract available


  277. LAWRENCE CL, Baldwin AS
    Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0165005.
    PubMed     Text format     Abstract available


  278. HREBIEN S, O'Leary B, Beaney M, Schiavon G, et al
    Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer.
    PLoS One. 2016;11:e0165023.
    PubMed     Text format     Abstract available


  279. FU J, Wu L, Jiang M, Li D, et al
    Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
    PLoS One. 2016;11:e0164921.
    PubMed     Text format     Abstract available


  280. SLAOUI M, Mouh FZ, Ghanname I, Razine R, et al
    Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution.
    PLoS One. 2016;11:e0164841.
    PubMed     Text format     Abstract available


  281. FORTENBERRY YM, Brandal SM, Carpentier G, Hemani M, et al
    Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.
    PLoS One. 2016;11:e0164288.
    PubMed     Text format     Abstract available


  282. ZHANG ZC, Xu QN, Lin SL, Li XY, et al
    Capecitabine in Combination with Standard (Neo)Adjuvant Regimens in Early Breast Cancer: Survival Outcome from a Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0164663.
    PubMed     Text format     Abstract available


  283. GONZALEZ-BENGTSSON A, Asadi A, Gao H, Dahlman-Wright K, et al
    Estrogen Enhances the Expression of the Polyunsaturated Fatty Acid Elongase Elovl2 via ERalpha in Breast Cancer Cells.
    PLoS One. 2016;11:e0164241.
    PubMed     Text format     Abstract available


  284. HAJIEBRAHIMI M, Montgomery S, Burkill S, Bahmanyar S, et al
    Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0165027.
    PubMed     Text format     Abstract available


  285. ZHANG Z, Luo G, Tang H, Cheng C, et al
    Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
    PLoS One. 2016;11:e0165725.
    PubMed     Text format     Abstract available


  286. HAN YJ, Zhang J, Zheng Y, Huo D, et al
    Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer.
    PLoS One. 2016;11:e0165559.
    PubMed     Text format     Abstract available


  287. HYUN SH, Ahn HK, Lee JH, Choi JY, et al
    Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
    PLoS One. 2016;11:e0165814.
    PubMed     Text format     Abstract available


  288. CHEN HL, Zhou MQ, Tian W, Meng KX, et al
    Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    PLoS One. 2016;11:e0165409.
    PubMed     Text format     Abstract available


  289. GREGORIO AC, Fonseca NA, Moura V, Lacerda M, et al
    Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model.
    PLoS One. 2016;11:e0165817.
    PubMed     Text format     Abstract available


  290. CHEN B, Dai D, Tang H, Ai X, et al
    Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0165133.
    PubMed     Text format     Abstract available


  291. SHIOTA T, Miyasato Y, Ohnishi K, Yamamoto-Ibusuki M, et al
    The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
    PLoS One. 2016;11:e0166680.
    PubMed     Text format     Abstract available


  292. HANIEH H, Mohafez O, Hairul-Islam VI, Alzahrani A, et al
    Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells.
    PLoS One. 2016;11:e0167650.
    PubMed     Text format     Abstract available


  293. GROSSET AA, Poirier F, Gaboury L, St-Pierre Y, et al
    Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.
    PLoS One. 2016;11:e0166731.
    PubMed     Text format     Abstract available


  294. SCOTT CM, Joo JE, O'Callaghan N, Buchanan DD, et al
    Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
    PLoS One. 2016;11:e0165436.
    PubMed     Text format     Abstract available


  295. WU Z, Liu Y, Li X, Li X, et al
    Resilience and Associated Factors among Mainland Chinese Women Newly Diagnosed with Breast Cancer.
    PLoS One. 2016;11:e0167976.
    PubMed     Text format     Abstract available


  296. GERNAAT SA, Isgum I, de Vos BD, Takx RA, et al
    Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT Scans of Breast Cancer Patients: Reproducibility and Association with Traditional Cardiovascular Risk Factors.
    PLoS One. 2016;11:e0167925.
    PubMed     Text format     Abstract available


  297. VAN HELMOND N, Steegers MA, Filippini-de Moor GP, Vissers KC, et al
    Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition.
    PLoS One. 2016;11:e0166601.
    PubMed     Text format     Abstract available


  298. TANINO H, Kosaka Y, Nishimiya H, Tanaka Y, et al
    BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    PLoS One. 2016;11:e0165721.
    PubMed     Text format     Abstract available


  299. YEH TC, Huang TT, Yeh TS, Chen YR, et al
    miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells.
    PLoS One. 2016;11:e0168171.
    PubMed     Text format     Abstract available


  300. PARK SY, Choi CH, Park JM, Chun M, et al
    A Patient-Specific Polylactic Acid Bolus Made by a 3D Printer for Breast Cancer Radiation Therapy.
    PLoS One. 2016;11:e0168063.
    PubMed     Text format     Abstract available


  301. HELLWIG B, Madjar K, Edlund K, Marchan R, et al
    Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.
    PLoS One. 2016;11:e0167585.
    PubMed     Text format     Abstract available


  302. FERNANDEZ-GALLARDO M, Gonzalez-Ramirez R, Sandoval A, Felix R, et al
    Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells.
    PLoS One. 2016;11:e0167445.
    PubMed     Text format     Abstract available


  303. KOTWINSKI P, Smith G, Cooper J, Sanders J, et al
    Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.
    PLoS One. 2016;11:e0165262.
    PubMed     Text format     Abstract available


  304. KANG EJ, Seo JH, Kim LY, Park GU, et al
    Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study.
    PLoS One. 2016;11:e0168469.
    PubMed     Text format     Abstract available


  305. LIU H, Wang G, Yang L, Qu J, et al
    Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/beta-Catenin Pathway.
    PLoS One. 2016;11:e0168406.
    PubMed     Text format     Abstract available


  306. TOKUNAGA E, Yamashita N, Tanaka K, Inoue Y, et al
    Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.
    PLoS One. 2016;11:e0168090.
    PubMed     Text format     Abstract available


  307. MORI H, Kubo M, Nishimura R, Osako T, et al
    BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer.
    PLoS One. 2016;11:e0167016.
    PubMed     Text format     Abstract available


  308. LIN J, Chen DR, Wang YF, Lai HW, et al
    Oncoplastic Surgery for Upper/Upper Inner Quadrant Breast Cancer.
    PLoS One. 2016;11:e0168434.
    PubMed     Text format     Abstract available


  309. FARAJI A, Dehghan Manshadi HR, Mobaraki M, Zare M, et al
    Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients.
    PLoS One. 2016;11:e0168519.
    PubMed     Text format     Abstract available


  310. WU ZH, Lin C, Liu MM, Zhang J, et al
    Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway.
    PLoS One. 2016;11:e0169230.
    PubMed     Text format     Abstract available


  311. GHOSH K, De S, Das S, Mukherjee S, et al
    Withaferin A Induces ROS-Mediated Paraptosis in Human Breast Cancer Cell-Lines MCF-7 and MDA-MB-231.
    PLoS One. 2016;11:e0168488.
    PubMed     Text format     Abstract available


  312. JIAO C, Cui L, Ma A, Li N, et al
    Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study.
    PLoS One. 2016;11:e0167498.
    PubMed     Text format     Abstract available


  313. CAMPBELL TM, Castro MA, Ponder BA, Meyer KB, et al
    Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.
    PLoS One. 2016;11:e0168770.
    PubMed     Text format     Abstract available


  314. REINERI S, Agati S, Miano V, Sani M, et al
    A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer Cells.
    PLoS One. 2016;11:e0168639.
    PubMed     Text format     Abstract available


  315. DIESSNER J, Wischnewsky M, Blettner M, Hausler S, et al
    Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.
    PLoS One. 2016;11:e0168730.
    PubMed     Text format     Abstract available


  316. KAZMIERCZAK PM, Todica A, Gildehaus FJ, Hirner-Eppeneder H, et al
    68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of alphavss3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.
    PLoS One. 2016;11:e0168248.
    PubMed     Text format     Abstract available


  317. BURKE NJ, Napoles TM, Banks PJ, Orenstein FS, et al
    Survivorship Care Plan Information Needs: Perspectives of Safety-Net Breast Cancer Patients.
    PLoS One. 2016;11:e0168383.
    PubMed     Text format     Abstract available


  318. FERRARIO C, Strepponi I, Esfahani K, Charamis H, et al
    Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer.
    PLoS One. 2016;11:e0167906.
    PubMed     Text format     Abstract available


    January 2015
  319. COSSU-ROCCA P, Orru S, Muroni MR, Sanges F, et al
    Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
    PLoS One. 2015;10:e0141763.
    PubMed     Text format     Abstract available


  320. POLI E, Zhang J, Nwachukwu C, Zheng Y, et al
    Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    PLoS One. 2015;10:e0142224.
    PubMed     Text format     Abstract available


  321. SATO C, Sekiguchi A, Kawai M, Kotozaki Y, et al
    Postoperative Structural Brain Changes and Cognitive Dysfunction in Patients with Breast Cancer.
    PLoS One. 2015;10:e0140655.
    PubMed     Text format     Abstract available


  322. FOYGEL K, Sekar TV, Paulmurugan R
    Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative Breast Cancer Therapy.
    PLoS One. 2015;10:e0141913.
    PubMed     Text format     Abstract available


  323. CARON JM, Caron JM
    Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells.
    PLoS One. 2015;10:e0141565.
    PubMed     Text format     Abstract available


  324. YOON HJ, Kim HN, Yun Y, Kim Y, et al
    Background Intestinal 18F-FDG Uptake Is Related to Serum Lipid Profile and Obesity in Breast Cancer Patients.
    PLoS One. 2015;10:e0141473.
    PubMed     Text format     Abstract available


  325. RASHID MU, Muzaffar M, Khan FA, Kabisch M, et al
    Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study.
    PLoS One. 2015;10:e0141562.
    PubMed     Text format     Abstract available


  326. LIM S, Park SH, Park HK, Hur MH, et al
    Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population.
    PLoS One. 2015;10:e0140208.
    PubMed     Text format     Abstract available


  327. RAMALHO SD, Sharma R, White JK, Aggarwal N, et al
    Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound.
    PLoS One. 2015;10:e0142527.
    PubMed     Text format     Abstract available


  328. BICKER A, Brahmer AM, Meller S, Kristiansen G, et al
    The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer.
    PLoS One. 2015;10:e0142662.
    PubMed     Text format     Abstract available


  329. ZHANG J, Huang Y, Wang X, Lin K, et al
    Environmental Polychlorinated Biphenyl Exposure and Breast Cancer Risk: A Meta-Analysis of Observational Studies.
    PLoS One. 2015;10:e0142513.
    PubMed     Text format     Abstract available


  330. NI H, Liu H, Gao R
    Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies.
    PLoS One. 2015;10:e0142669.
    PubMed     Text format     Abstract available


  331. SRINIVAS C, Ramaiah MJ, Lavanya A, Yerramsetty S, et al
    Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer.
    PLoS One. 2015;10:e0142006.
    PubMed     Text format     Abstract available


  332. GAO N, Zhai Q, Li Y, Huang K, et al
    Clinical Implications of TbetaRII Expression in Breast Cancer.
    PLoS One. 2015;10:e0141412.
    PubMed     Text format     Abstract available


  333. ZHANG M, Zhang S, Wen Y, Wang Y, et al
    DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.
    PLoS One. 2015;10:e0142279.
    PubMed     Text format     Abstract available


  334. BERETOV J, Wasinger VC, Millar EK, Schwartz P, et al
    Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    PLoS One. 2015;10:e0141876.
    PubMed     Text format     Abstract available


  335. HUANG J, Yu Y, Wei C, Qin Q, et al
    Harmonic Scalpel versus Electrocautery Dissection in Modified Radical Mastectomy for Breast Cancer: A Meta-Analysis.
    PLoS One. 2015;10:e0142271.
    PubMed     Text format     Abstract available


  336. LEVENSON RM, Krupinski EA, Navarro VM, Wasserman EA, et al
    Pigeons (Columba livia) as Trainable Observers of Pathology and Radiology Breast Cancer Images.
    PLoS One. 2015;10:e0141357.
    PubMed     Text format     Abstract available


  337. JIA W, Wu J, Jia H, Yang Y, et al
    The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    PLoS One. 2015;10:e0143061.
    PubMed     Text format     Abstract available


  338. WAWRUSZAK A, Luszczki JJ, Grabarska A, Gumbarewicz E, et al
    Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
    PLoS One. 2015;10:e0143013.
    PubMed     Text format     Abstract available


  339. JANG DH, Kim MW, Oh SJ, Kim JM, et al
    The Influence of Arm Swelling Duration on Shoulder Pathology in Breast Cancer Patients with Lymphedema.
    PLoS One. 2015;10:e0142950.
    PubMed     Text format     Abstract available


  340. SCHUMMER M, Thorpe J, Giraldez M, Bergan L, et al
    Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
    PLoS One. 2015;10:e0142911.
    PubMed     Text format     Abstract available


  341. OLADIMEJI KE, Tsoka-Gwegweni JM, Igbodekwe FC, Twomey M, et al
    Knowledge and Beliefs of Breast Self-Examination and Breast Cancer among Market Women in Ibadan, South West, Nigeria.
    PLoS One. 2015;10:e0140904.
    PubMed     Text format     Abstract available


  342. CHUANG SC, Wu GJ, Lu YS, Lin CH, et al
    Associations between Medical Conditions and Breast Cancer Risk in Asians: A Nationwide Population-Based Study in Taiwan.
    PLoS One. 2015;10:e0143410.
    PubMed     Text format     Abstract available


  343. WANG J, Kato F, Oyama-Manabe N, Li R, et al
    Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study.
    PLoS One. 2015;10:e0143308.
    PubMed     Text format     Abstract available


  344. WEN J, Ye F, Li S, Huang X, et al
    The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment.
    PLoS One. 2015;10:e0143537.
    PubMed     Text format     Abstract available


  345. MU QJ, Li HL, Yao Y, Liu SC, et al
    Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
    PLoS One. 2015;10:e0143030.
    PubMed     Text format     Abstract available


  346. CALDERON LE, Liu S, Arnold N, Breakall B, et al
    Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration.
    PLoS One. 2015;10:e0143277.
    PubMed     Text format     Abstract available


  347. PEI L, Zhou Y, Tan G, Mao F, et al
    Ultrasound-Assisted Thoracic Paravertebral Block Reduces Intraoperative Opioid Requirement and Improves Analgesia after Breast Cancer Surgery: A Randomized, Controlled, Single-Center Trial.
    PLoS One. 2015;10:e0142249.
    PubMed     Text format     Abstract available


  348. HASEGAWA Y, Tanino H, Horiguchi J, Miura D, et al
    Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study).
    PLoS One. 2015;10:e0143643.
    PubMed     Text format     Abstract available


  349. BAYERLOVA M, Klemm F, Kramer F, Pukrop T, et al
    Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data.
    PLoS One. 2015;10:e0144014.
    PubMed     Text format     Abstract available


  350. TAN SH, Sapari NS, Miao H, Hartman M, et al
    High-Throughput Mutation Profiling Changes before and 3 Weeks after Chemotherapy in Newly Diagnosed Breast Cancer Patients.
    PLoS One. 2015;10:e0142466.
    PubMed     Text format     Abstract available


  351. JIN YY, Andrade J, Wickstrom E
    Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity.
    PLoS One. 2015;10:e0142574.
    PubMed     Text format     Abstract available


  352. LI LD, Sun HF, Liu XX, Gao SP, et al
    Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism.
    PLoS One. 2015;10:e0144441.
    PubMed     Text format     Abstract available


  353. STRUMYLAITE L, Sharp SJ, Kregzdyte R, Poskiene L, et al
    The Association of Low-To-Moderate Alcohol Consumption with Breast Cancer Subtypes Defined by Hormone Receptor Status.
    PLoS One. 2015;10:e0144680.
    PubMed     Text format     Abstract available


  354. OLSSON E, Winter C, George A, Chen Y, et al
    Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.
    PLoS One. 2015;10:e0144528.
    PubMed     Text format     Abstract available


  355. CANDELARIA NR, Weldon R, Muthusamy S, Nguyen-Vu T, et al
    Alcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer Cells.
    PLoS One. 2015;10:e0145061.
    PubMed     Text format     Abstract available


  356. SCHWICKERT A, Weghake E, Bruggemann K, Engbers A, et al
    microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.
    PLoS One. 2015;10:e0143993.
    PubMed     Text format     Abstract available


  357. YOO TK, Min JW, Kim MK, Lee E, et al
    In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients.
    PLoS One. 2015;10:e0144144.
    PubMed     Text format     Abstract available


  358. ZHANG ZQ, Han YZ, Nian Q, Chen G, et al
    Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (</=35 Years).
    PLoS One. 2015;10:e0144376.
    PubMed     Text format     Abstract available


  359. HE ZY, Wu SG, Zhou J, Li FY, et al
    Correction: Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes.
    PLoS One. 2015;10:e0145972.
    PubMed     Text format     Abstract available


  360. SRIRAM N, Mills J, Lang E, Dickson HK, et al
    Attitudes and Stereotypes in Lung Cancer versus Breast Cancer.
    PLoS One. 2015;10:e0145715.
    PubMed     Text format     Abstract available


  361. KARLSSON E, Magic I, Bostner J, Dyrager C, et al
    Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.
    PLoS One. 2015;10:e0145013.
    PubMed     Text format     Abstract available


  362. SCHNECK H, Gierke B, Uppenkamp F, Behrens B, et al
    EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    PLoS One. 2015;10:e0144535.
    PubMed     Text format     Abstract available


  363. JWA E, Shin KH, Lim HW, Jung SY, et al
    Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
    PLoS One. 2015;10:e0145463.
    PubMed     Text format     Abstract available


  364. CHANG TH, Hsu HH, Chou YC, Yu JC, et al
    The Values of Combined and Sub-Stratified Imaging Scores with Ultrasonography and Mammography in Breast Cancer Subtypes.
    PLoS One. 2015;10:e0145390.
    PubMed     Text format     Abstract available


  365. BONSANG-KITZIS H, Chaltier L, Belin L, Savignoni A, et al
    Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
    PLoS One. 2015;10:e0144359.
    PubMed     Text format     Abstract available


  366. TAKI S, Kamada H, Inoue M, Nagano K, et al
    A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy.
    PLoS One. 2015;10:e0144712.
    PubMed     Text format     Abstract available


  367. KIM SY, Park SE, Shim SM, Park S, et al
    Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells.
    PLoS One. 2015;10:e0146073.
    PubMed     Text format     Abstract available


  368. CAO L, Yao GY, Liu MF, Chen LJ, et al
    Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials.
    PLoS One. 2015;10:e0145442.
    PubMed     Text format     Abstract available


  369. BOWERS LW, Wiese M, Brenner AJ, Rossi EL, et al
    Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway.
    PLoS One. 2015;10:e0145452.
    PubMed     Text format     Abstract available


  370. KHALIQ W, Aamar A, Wright SM
    Predictors of Non-Adherence to Breast Cancer Screening among Hospitalized Women.
    PLoS One. 2015;10:e0145492.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: